Order Article Reprints

Tsimafeyeu I, Chubenko V, Baklanova O, Kalpinskiy A, Safina S, Lebedinets A, Petkau V, Parsadanova E, Turganova M, Shkurat A, et al. Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study. Current Oncology. 2025; 32(1):11. https://doi.org/10.3390/curroncol32010011

Tsimafeyeu, Ilya, Vyacheslav Chubenko, Olga Baklanova, Alexey Kalpinskiy, Sufia Safina, Andrei Lebedinets, Vladislav Petkau, Elvira Parsadanova, Maria Turganova, Aleksei Shkurat, and et al. 2025. "Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study" Current Oncology 32, no. 1: 11. https://doi.org/10.3390/curroncol32010011

Tsimafeyeu, I., Chubenko, V., Baklanova, O., Kalpinskiy, A., Safina, S., Lebedinets, A., Petkau, V., Parsadanova, E., Turganova, M., Shkurat, A., Tovbik, N., Tkacheva, E., Anzhiganova, Y., Novikova, O., Bragina, V., Zukov, R., & Orlova, R. (2025). Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study. Current Oncology, 32(1), 11. https://doi.org/10.3390/curroncol32010011